XORTX Therapeutics Inc. (XRTX)
NASDAQ: XRTX · IEX Real-Time Price · USD
3.825
+0.025 (0.66%)
At close: Mar 25, 2024, 4:00 PM
3.610
-0.215 (-5.62%)
Pre-market: Mar 28, 2024, 8:51 AM EDT
XORTX Therapeutics Market Cap
XORTX Therapeutics has a market cap or net worth of $11.01 million as of March 28, 2024. Its market cap has increased by 80.57% in one year.
Market Cap
11.01M
Enterprise Value
5.97M
1-Year Change
80.57%
Ranking
Category
Stock Price
$3.83
Market Cap Chart
Since October 14, 2021, XORTX Therapeutics's market cap has decreased from $38.20M to $11.01M, a decrease of -71.17%. That is a compound annual growth rate of -39.78%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Mar 27, 2024 | 7.20M | -5.26% |
Mar 26, 2024 | 7.60M | - |
Mar 25, 2024 | 7.60M | -14.61% |
Mar 22, 2024 | 8.90M | -8.25% |
Mar 21, 2024 | 9.70M | 10.23% |
Mar 20, 2024 | 8.80M | -11.11% |
Mar 19, 2024 | 9.90M | 2.06% |
Mar 18, 2024 | 9.70M | -5.83% |
Mar 15, 2024 | 10.30M | -4.63% |
Mar 14, 2024 | 10.80M | 9.09% |
Mar 13, 2024 | 9.90M | 2.06% |
Mar 12, 2024 | 9.70M | 8.99% |
Mar 11, 2024 | 8.90M | -6.32% |
Mar 8, 2024 | 9.50M | 3.26% |
Mar 7, 2024 | 9.20M | -26.40% |
Mar 6, 2024 | 12.50M | 30.21% |
Mar 5, 2024 | 9.60M | 39.13% |
Mar 4, 2024 | 6.90M | 6.15% |
Mar 1, 2024 | 6.50M | 6.56% |
Feb 29, 2024 | 6.10M | -8.96% |
Feb 28, 2024 | 6.70M | 21.82% |
Feb 27, 2024 | 5.50M | -1.79% |
Feb 26, 2024 | 5.60M | 16.67% |
Feb 23, 2024 | 4.80M | -11.11% |
Feb 22, 2024 | 5.40M | 10.20% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
VBI Vaccines | 13.63M |
Edesa Biotech | 13.58M |
Can-Fite BioPharma | 13.48M |
Biotricity | 13.19M |
Flora Growth | 12.97M |
Eterna Therapeutics | 12.88M |
Benitec Biopharma | 12.83M |
Addex Therapeutics | 12.50M |